18 results
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities;
changes
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Report of Foreign Private Issuer
8:15am
: Positive Regulatory Interaction, Buildup of Plant & Supply Chain Infrastructure On Schedule
Construction of Enlivex’s new cGMP Allocetra™ … occur if it receives applicable regulatory approvals. The Company’s efforts to establish supply chain infrastructure to support potential
424B5
1kgo4bt9 g2et
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
985g9e7
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.2
c284ar4enw lx1
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
424B5
gqkb47y86soby 1gu
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.2
2ndbwlzt36 pogish2j
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
ixwp6ffh
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
20-F
8phzpuw murxb6yco
31 Mar 15
Annual report (foreign)
12:00am
424B4
17fm xg4vcqb9nj2r
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
z6s8is9njtkvo6ll
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next